首页 >
法规速递
-
Document: Agenda of the COMP meeting 4-6 November 2025-2025/11/3
2025-11-04查看详情 > -
关于将安瑞替尼胶囊纳入“儿童抗肿瘤药物研发鼓励试点计划（星光计划）”试点项目的通知-2025/12/3
2025-12-04查看详情 > -
Document: HMA-EMA Network Data Steering Group: membership list-2026/1/6
2026-01-07查看详情 > -
Document: Minutes of the CHMP meeting 16-19 June 2025-2026/2/10
2026-02-11查看详情 > -
Document: Innovation Task Force (ITF) briefing meeting request form-2026/3/19
2026-03-20查看详情 > -
Document: Product Management Service (PMS) – Frequently Asked Questions (FAQs)-2026/4/23
2026-04-24查看详情 > -
国家药监局关于修订己酮可可碱注射剂说明书的公告（2022年第85号）-2022/10/18
2022-11-14查看详情 > -
Regulatory and procedural guideline: Draft Qualification Opinion for Stride velocity 95th centile as primary endpoint in studies in ambulatory Duchenne Muscular Dystrophy-2023/03/01
2023-03-01查看详情 > -
Final Guidance: Annual Status Report Information and Other Submissions for Postmarketing Requirements and Commitments: Using Forms FDA 3988 and FDA 3989 Guidance for Industry-2023/9/14
2023-09-15查看详情 > -
CVM GFI #260 - Type VII Veterinary Master File for Research and Development and Risk Reviews-2025/1/7
2025-01-07查看详情 >
